OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Preventive Cardiology is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
COP27 Climate Change Conference: urgent action needed for Africa and the world	235
Prime Time for (im) Precision Medicine: From Randomized Clinical Trials to Real-World Evidence	193
Preventing atherosclerosis: rethinking the starting line	184
Effect of semaglutide on mortality and cardiovascular events in patients at high cardiovascular risk: an updated systematic review and meta-analysis	177
Integrating lipoprotein(a) into preventive cardiology: probably important to get the measurement right	157
Early adulthood exercise capacity, but not muscle strength, associates with subclinical atherosclerosis 40 years later in Swedish men	140
Anabolic steroids in athletes: the interplay of hormones and inflammation leading to the heart’s vulnerability	108
The ‘environmental exposome’ as a target to reimagine the cardiovascular prevention	105
The prevalence and clinical significance of a reduced ventricular ejection fraction in asymptomatic young elite endurance athletes	103
Visceral adiposity, aortic stiffness, and cardiovascular risk	96
Respiratory Vaccines as Cardiovascular Prevention: Evidence from Four Landmark Trials	94
Increasing Pneumococcal Vaccination in Patients with Heart Failure: A Scalable Public Health Strategy	93
The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank	80
The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice	79
Global magnitude and temporal trend of infective endocarditis, 1990–2019: results from the Global Burden of Disease Study	76
Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women?	69
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from	68
Sex specific association of body composition with sphingosine-1-phosphate levels-results from the study of health in pomerania (SHIP) analysis	64
Cardiorespiratory fitness in relation to systolic and diastolic function in patients with heart failure and chronic coronary syndromes	64
Prevalence of ventricular arrhythmias in apparently healthy workers: results from Ferrari Formula Benessere	62
Characteristics and risk of coronary-related events following hospitalisation for chronic coronary disease	61
Type D personality, cardiovascular risk factors and risk of recurrent major adverse cardiac events in outpatients with coronary heart disease	60
Evaluation of the age-related prevalence of cardiovascular risk factors to guide systematic long-term follow-up after preeclampsia	57
Modulation of sympathetic nervous system activity through various therapeutic approaches in patients with resistant hypertension and heart failure with preserved ejection fraction	57
Exercise doppler Echocardiography of the right heart and pulmonary circulation in patients with cardiovascular risk factors: observations from the RIGHT Heart International NETwork (RIGHT-NET)	57

Temporal trends and outcomes of cardiac rehabilitation after acute coronary syndrome in an asian population	56
Statin therapy eligibility in a large primary prevention cohort according to European Society of Cardiology Guidelines	55
Sports-related sudden cardiac arrest: a video analysis of characteristics and outcomes	52
Temporal trends in myocardial infarction case fatality: methodological challenges and prevention targets	50
The role of the arrhythmologist in a sports cardiology centre: the devil is in the detail	47
Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease	47
Secondary prevention of Coronary Heart Disease (CHD) in the Moroccan population. Survey of Risk Factor (SURF) CHD II Morocco	47
Improvements in walking speed reduce mortality in patients with cardiovascular disease during exercise-based secondary prevention: findings from the ITER registry	46
Enhancement of left ventricular compliance in twin pregnancy	46
Treatment of iron deficiency anemia after cardiac surgery	46
Carotid intima-media thickness progression and plaque formation in recreational male endurance athletes - a 10-year follow-up study	45
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study	45
Association of cardiorespiratory fitness measured by cardiopulmonary exercise testing with covid-19 positivity: a prospective register-based cohort study	44
Effects of a behavioral psychological intervention in addition to an exercise rehabilitation program in chronic heart failure patients	44
Effect of preventive training in cardiac transcriptoma in rats with pulmonary hypertension	42
Effect of hybrid cardiac rehabilitation using a smart device: a randomized controlled trial	40
Baroreflex: ready for prime-time?	40